Key facts
| Price (PPV) | 452 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | indacaterol |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03AC18 |
| Manufacturer | NOVARTIS PHARMA MAROC |
| Presentation | Boite de 30 gélules de poudre d'inhalation |
| Nature | Médicament |
| Hospital price | 300 MAD |
| Data collected on | 9/8/2026 |
Indications
Onbrez Breezhaler est indiqué dans le traitement bronchodilatateur d'entretien lors d'obstructions des voies aériennes chez les adultes avec bronchopneumopathie chronique obstructive (BPCO). Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Onbrez Breezhaler 150 µg
Onbrez Breezhaler 150 µg belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Onbrez Breezhaler 150 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Onbrez Breezhaler 150 µg
Answers to common questions from Moroccan patients about this drug.